We are live on ! Find out more
JCM

Jacobi Capital Management Portfolio holdings

AUM $2.04B
1-Year Est. Return 26.26%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+26.26%
3 Year Est. Return
+76.57%
5 Year Est. Return
+89.08%
10 Year Est. Return
+253.33%
AUM
$548M
AUM Growth
+$42.8M
Cap. Flow
+$5.29M
Cap. Flow %
0.96%
Top 10 Hldgs %
36.87%
Holding
1,138
New
47
Increased
346
Reduced
163
Closed
28

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$14.1M
2
IYR icon
iShares US Real Estate ETF
IYR
+$6.6M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$2.79M
4
PEP icon
PepsiCo
PEP
+$975K
5
XOM icon
ExxonMobil
XOM
+$907K

Top Sells

Rank Stock Value
1
BND icon
Vanguard Total Bond Market
BND
+$12.9M
2
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$6.62M
3
EW icon
Edwards Lifesciences
EW
+$4.62M
4
VCLT icon
Vanguard Long-Term Corporate Bond ETF
VCLT
+$3.24M
5
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$2.31M

Sector Composition

Rank Sector Weight
1 Financials 11.09%
2 Healthcare 8.2%
3 Technology 7.41%
4 Industrials 6.02%
5 Consumer Staples 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIAB
1126
DELISTED
Viacom Inc. Class B
VIAB
– –
-948
Closed -$23K
GHDX
1127
DELISTED
Genomic Health, Inc.
GHDX
– –
-100
Closed -$7K
ISCA
1128
DELISTED
International Speedway Corp
ISCA
– –
-28
Closed -$1K
VSM
1129
DELISTED
Versum Materials, Inc.
VSM
– –
-538
Closed -$28K
AABA
1130
DELISTED
Altaba Inc
AABA
– –
-360
Closed -$7K
NVIV
1131
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
– –
0
– –
CRC
1132
DELISTED
California Resources Corporation
CRC
$0 ﹤0.01%
22
– –
CPAH
1133
DELISTED
Counterpath Corp
CPAH
$0 ﹤0.01%
20
– –
VIA
1134
DELISTED
Viacom Inc. Class A
VIA
– –
-525
Closed -$14K
VVUS
1135
DELISTED
Vivus Inc
VVUS
$0 ﹤0.01%
24
– –
SPHS
1136
DELISTED
Sophiris Bio, Inc.
SPHS
$0 ﹤0.01%
400
– –
CELG
1137
DELISTED
Celgene Corp
CELG
– –
-4,398
Closed -$437K
AIM
1138
AIM ImmunoTech
AIM
$7.03M
– –
0
– –
42 43 44 45
46

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
BMCM
Bryn Mawr Capital Management Philadelphia, Pennsylvania $2.06B AUM 19.82% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return

Jacobi Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Jacobi Capital Management held 1,138 positions worth $548M, up 8.5% from $505M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jacobi Capital Management's Q4 2019 filing shows 47 new, 346 increased, 163 reduced and 28 closed positions. Its largest new stake was Carlisle Companies: 1,500 shares worth $243K. The largest sale was Vanguard Total Bond Market, an estimated $12.9M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

  • Jacobi Capital Management's largest Q4 2019 buy was Carlisle Companies: 1,500 shares worth $243K.
  • Jacobi Capital Management added most to Vanguard FTSE All-World ex-US ETF in Q4 2019, an estimated $14.1M increase.
  • Jacobi Capital Management's biggest Q4 2019 reduction was Vanguard Total Bond Market, cutting an estimated $12.9M.
  • Jacobi Capital Management fully exited Vanguard Long-Term Corporate Bond ETF in Q4 2019, selling an estimated $3.24M.
  • Jacobi Capital Management's ten largest holdings make up 37% of its $548M portfolio in Q4 2019.
  • Jacobi Capital Management opened 47 new positions and closed 28 in Q4 2019.
  • Jacobi Capital Management's portfolio value rose 8.5% quarter-over-quarter to $548M.

Based on Jacobi Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.